37 related articles for article (PubMed ID: 36604174)
21. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease.
Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J
Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of drug coated balloon angioplasty for intracranial atherosclerotic disease.
Qiao H; Chang CH; Wang AY; Li S; Yang W; Li G; Cen X; Wang R; Lin H
J Neurointerv Surg; 2023 Nov; 15(e2):e172-e177. PubMed ID: 36171100
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
Ueda T; Takaishi S; Yoshie T; Usuki N; Tatsuno K; Ohtsubo H; Araga T; Kaga Y; Takada T
BMC Neurol; 2022 Dec; 22(1):477. PubMed ID: 36510182
[TBL] [Abstract][Full Text] [Related]
24. Plaque modification and stabilization after drug-coated balloon angioplasty for intracranial atherosclerotic lesions.
Meng Y; Zhang Y; Chu X; Song Y; Zhao W; Zheng M; Zhang J; Han J
Eur Radiol; 2023 Feb; 33(2):1112-1120. PubMed ID: 36136108
[TBL] [Abstract][Full Text] [Related]
25. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
Herten M; Torsello GB; Schönefeld E; Stahlhoff S
Vasc Health Risk Manag; 2016; 12():341-56. PubMed ID: 27621646
[TBL] [Abstract][Full Text] [Related]
26. Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis.
Tang Y; Li T; Liu W; He Y; Zhu L; Wang ZL; He Y
J Neurointerv Surg; 2023 Dec; 15(e3):e369-e374. PubMed ID: 36604174
[TBL] [Abstract][Full Text] [Related]
27. Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review.
Li G; Qiao H; Lin H; Wang R; Chen F; Li S; Yang W; Yin L; Cen X; Zhang Y; Cheng X; Wang AY
Clin Neurol Neurosurg; 2022 Feb; 213():107065. PubMed ID: 34991058
[TBL] [Abstract][Full Text] [Related]
28. Using drug-coated balloons for symptomatic vertebral artery origin stenosis: A systematic review and meta-Analysis.
Wu S; Yin Y; Li Z; Li N; Ma W; Zhang L
J Clin Neurosci; 2023 Jan; 107():98-105. PubMed ID: 36527812
[TBL] [Abstract][Full Text] [Related]
29. Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta-analysis.
Zhang Y; Yuan FL; Hu XY; Wang QB; Zou ZW; Li ZG
Clin Cardiol; 2023 Aug; 46(8):877-885. PubMed ID: 37417371
[TBL] [Abstract][Full Text] [Related]
30. Device profile of different paclitaxel-coated balloons: Neuro Elutax SV, Elutax '3' Neuro and SeQuent Please NEO for the treatment of symptomatic intracranial high-grade stenosis: overview of their feasibility and safety.
Gruber P; Remonda L
Expert Rev Med Devices; 2020 Feb; 17(2):87-92. PubMed ID: 31962054
[No Abstract] [Full Text] [Related]
31. The Role of Drug-Coated Balloon in Haemodialysis Arteriovenous Fistula Stenosis Management.
Da Zhuang K; Irani FG; Gogna A; Too CW; Tan BS; Tay KH
Cardiovasc Intervent Radiol; 2023 Sep; 46(9):1144-1153. PubMed ID: 37414842
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
